EURAZEO SELLS PETERS SURGICAL TO ADVANCED MEDICAL SOLUTIONS

Eurazeo, following its Small-mid buyout strategy, and the management of Peters Surgical have reached an agreement to divest the entire share capital of Peters Surgical to Advanced Medical Solutions Group plc (AMS), a leading entity in the UK focusing on tissue-healing technologies. This strategic move was announced on March 13, 2024, from Paris. Peters Surgical, known for its specialization in surgical sutures, mechanical haemostasis, and internal cyanoacrylate devices, has grown under Eurazeo's majority ownership since 2013.

The acquisition by AMS is poised to create synergies by combining product portfolios, enhancing sales capabilities, and expanding the commercial and distribution footprint across crucial markets. This development is still awaiting the green light from French regulatory bodies overseeing foreign investments. Expected proceeds from this sale total approximately €66 million, with about €46 million benefiting Eurazeo's balance sheet, subject to adjustments and potential earn-outs in the next two years.